GEV vs MELI: Which Is the Better Buy?

Side-by-side comparison of GE Vernova Inc. and MercadoLibre, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
GE Vernova Inc. ยท Industrials
$951.82
+35.4% upside to fair value
Med Conviction Grade B High Quality
VS
MercadoLibre, Inc. ยท Consumer Cyclical
$1,828.94
+25.8% upside to fair value
Med Conviction Grade B+ High Quality
QuantHub Verdict
GEV has more upside to fair value (+35.4%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric GEV MELI
Current Price $951.82 $1,828.94
Fair Value Estimate $1,288.67 $2,300.00
Upside to Fair Value +35.4% +25.8%
Market Cap $253.5B $92.7B
Forward P/E โ€” โ€”
EV / EBITDA 28.2x 33.0x
Price / Sales 6.1x 2.6x
Price / FCF 20.5x 7.4x
Revenue Growth YoY +21.9% +49.8%
Gross Margin 20.2% 42.7%
Operating Margin 4.4% 8.3%
Return on Equity 83.4% 26.5%
Dividend Yield 0.18% 0%
FCF Yield 4.88% 13.44%
Analyst Consensus Strong Buy Buy
Investment Thesis
GEV โ€” GE Vernova Inc.
GE Vernova is an energy equipment and infrastructure enterprise spanning Power (gas, nuclear, hydro, steam), Wind (offshore and onshore turbines), and Electrification (grid, power conversion, solar and storage), with 78,000 employees and a Cambridge, Massachusetts headquarters. The business quality is high on the strength of an installed base that generates roughly 25% of the world's electricity,โ€ฆ
MELI โ€” MercadoLibre, Inc.
MercadoLibre operates Latin America's leading ecommerce marketplace alongside Mercado Pago payments, credit, logistics, advertising and loyalty products, creating a broad ecosystem with meaningful network effects and cross-sell. Business momentum remains strong: revenue and financial income grew 49.8% year over year in the most recent quarter to $10.169 billion, GMV increased 44%, TPV rose 56%, aโ€ฆ
Accumulation Zones
Metric GEV MELI
Zone Low $966.50 $1,725.00
Zone High $1,095.37 $1,955.00
In Buy Zone? Yes Yes
โ† GEV Research    MELI Research โ†’    All Research